Table 2.
In-hospital events and treatment strategy
| Variables |
No catecholamines
(n = 93) |
catecholamines
(n = 21) |
p value* |
|---|---|---|---|
| Life-threatening arrhythmia | 6 (6.45) | 7 (33.33) | < 0.01 |
| NPPV and intubation | 21 (22.5) | 18 (85.7) | < 0.01 |
| Resuscitation | 3 (3.22) | 6 (28.57) | < 0.01 |
| Defibrillator-Implantation | 1 (1.0) | 1 (4.7) | 0.33 |
| VA-ECMO | 0 (0) | 1 (4.7) | 0.18 |
| Admission to ICU, length of stay | 3.24 ± 3.59 | 9.57 ± 11.32 | < 0.01 |
| In-hospital death | 3 (3.2) | 6 (28.5) | < 0.01 |
| Thromboembolic events | 10 (10.75) | 4 (19.04) | 0.29 |
| Acquired Long QTs | 61 (65.59) | 12 (57.14) | 0.41 |
| Cardiogenic Shock | 4 (4.30) | 18 (85.71) | < 0.01 |
*p values for the comparison between no catecholamines and catecholamines; NPPV Noninvasive positive pressure ventilation, VA-ECMO Veno-arterial extracorporal membrane oxygenation, ICU Intermediate care unit
The bolded indication highlight significant values